deuterium has been researched along with Dyslipidemias in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bateman, K; Chan, CC; Huang, Z; Landry, F; Leclair, G; Li, CS; Oballa, R; Zhang, L | 1 |
Adiels, M; Borén, J; Caslake, MJ; Olofsson, SO; Packard, C; Soro, A; Stewart, P; Taskinen, MR; Wennberg, B; Westerbacka, J | 1 |
1 trial(s) available for deuterium and Dyslipidemias
Article | Year |
---|---|
Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia.
Topics: Adult; Apolipoproteins B; Blood Glucose; Cholesterol, HDL; Cholesterol, VLDL; Deuterium; Diabetes Mellitus, Type 2; Dyslipidemias; Glycerol; Humans; Hyperglycemia; Insulin Resistance; Leucine; Male; Triglycerides | 2005 |
1 other study(ies) available for deuterium and Dyslipidemias
Article | Year |
---|---|
Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors.
Topics: Acetates; Animals; Biological Assay; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Deuterium; Diabetes Mellitus; Dyslipidemias; Enzyme Inhibitors; Humans; Liver; Male; Mass Spectrometry; Molecular Targeted Therapy; Oleic Acid; Plasma; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase; Tetrazoles | 2011 |